{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T17:17:29Z","timestamp":1792343849602,"version":"4.4.0"},"reference-count":167,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Psychology Review"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.cpr.2026.102706","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:30:18Z","timestamp":1770078618000},"page":"102706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review"],"prefix":"10.1016","volume":"124","author":[{"given":"J.K.E.","family":"Veraart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Schimmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Breeksema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Seybert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kamphuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.F.T.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.T.","family":"Coerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Oliveira-Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Schoevers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/JCP.0000000000000659","article-title":"Intranasal ketamine and cognitive-behavioral therapy for treatment-refractory obsessive-compulsive disorder","volume":"37","author":"Adams","year":"2017","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0010","first-page":"24","article-title":"Ketamine-hypnosis package (KHP): A clinical case study for the treatment of depression and addiction administering ketamine with hypnotherapy","volume":"2","author":"Adler","year":"2020","journal-title":"The Journal of Psychedelic Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0015","unstructured":"Anderson, C. M. (2023). Treating trauma-related symptoms with ketamine-assisted psychotherapy: A program evaluation University of Arizona]. Tucson."},{"key":"10.1016\/j.cpr.2026.102706_bb0020","unstructured":"Anderson, C. M. (2024). Treating trauma-related symptoms with ketamine-assisted psychotherapy: A program evaluation ProQuest Information & Learning]. Psyh. http:\/\/search.ebscohost.com.proxy-ub.rug.nl\/login.aspx?direct=true&db=psyh&AN=2024-49612-146&site=ehost-live&scope=site."},{"key":"10.1016\/j.cpr.2026.102706_bb0025","series-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"1952"},{"key":"10.1016\/j.cpr.2026.102706_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1197409","article-title":"Case report: Improvement in refractory functional seizures, depression, and quality of life with ketamine-assisted therapy [article]","volume":"17","author":"Argento","year":"2023","journal-title":"Frontiers in Neuroscience"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0035","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00952990.2020.1808982","article-title":"Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study","volume":"47","author":"Azhari","year":"2021","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"6","key":"10.1016\/j.cpr.2026.102706_bb0040","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/14740338.2022.2047928","article-title":"Efficacy and safety of racemic ketamine and esketamine for depression: A systematic review and meta-analysis","volume":"21","author":"Bahji","year":"2022","journal-title":"Expert Opinion on Drug Safety"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/ACO.0000000000000916","article-title":"Ketamine: A versatile tool for anesthesia and analgesia","volume":"33","author":"Barrett","year":"2020","journal-title":"Current Opinion in Anaesthesiology"},{"key":"10.1016\/j.cpr.2026.102706_bb0050","series-title":"Cognitive therapy of depression","author":"Beck","year":"1979"},{"key":"10.1016\/j.cpr.2026.102706_bb0055","article-title":"Beck depression inventory\u2013II","author":"Beck","year":"1996","journal-title":"Psychological Assessment"},{"key":"10.1016\/j.cpr.2026.102706_bb0060","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0006-3223(99)00230-9","article-title":"Antidepressant effects of ketamine in depressed patients","volume":"47","author":"Berman","year":"2000","journal-title":"Biological Psychiatry"},{"issue":"8","key":"10.1016\/j.cpr.2026.102706_bb0070","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0005-7967(96)00033-2","article-title":"Psychometric properties of the PTSD checklist (PCL)","volume":"34","author":"Blanchard","year":"1996","journal-title":"Behaviour Research and Therapy"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0075","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1080\/10550490290088126","article-title":"Ketamine as a preferred substance of abuse","volume":"11","author":"Bobo","year":"2002","journal-title":"The American Journal on Addictions"},{"issue":"10","key":"10.1016\/j.cpr.2026.102706_bb0080","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/02698811221116926","article-title":"Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review","volume":"36","author":"Breeksema","year":"2022","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.cpr.2026.102706_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.948115","article-title":"Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study","volume":"13","author":"Breeksema","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"7","key":"10.1016\/j.cpr.2026.102706_bb0090","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00213-023-06388-6","article-title":"Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: An interpretative phenomenological study","volume":"240","author":"Breeksema","year":"2023","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0095","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.ekir.2022.12.015","article-title":"Ketamine-induced acute interstitial nephritis","volume":"8","author":"Brucculeri","year":"2023","journal-title":"Kidney International Reports"},{"key":"10.1016\/j.cpr.2026.102706_bb0100","doi-asserted-by":"crossref","unstructured":"Budd, R., & Hughes, I. (2009). The Dodo Bird Verdict--controversial, inevitable and important: a commentary on 30 years of meta-analyses. Clinical Psychology & Psychotherapy, 16(6), 510\u2013522. doi:https:\/\/doi.org\/10.1002\/cpp.648.","DOI":"10.1002\/cpp.648"},{"issue":"7","key":"10.1016\/j.cpr.2026.102706_bb0105","first-page":"28","article-title":"The clinical global impressions scale: Applying a research tool in clinical practice","volume":"4","author":"Busner","year":"2007","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.cpr.2026.102706_bb0110","doi-asserted-by":"crossref","unstructured":"Cain, D. J. (2010). Humanistic psychotherapies. In the Corsini encyclopedia of psychology (pp. 1-4). doi:https:\/\/doi.org\/10.1002\/9780470479216.corpsy0423.","DOI":"10.1002\/9780470479216.corpsy0423"},{"key":"10.1016\/j.cpr.2026.102706_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.887255","article-title":"Psychedelic-assisted psychotherapy-A systematic review of associated psychological interventions","volume":"13","author":"Cavarra","year":"2022","journal-title":"Frontiers in Psychology"},{"issue":"9","key":"10.1016\/j.cpr.2026.102706_bb0120","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s40263-021-00846-5","article-title":"Prevention and Management of Common Adverse Effects of ketamine and Esketamine in patients with mood disorders","volume":"35","author":"Ceban","year":"2021","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12888-023-05468-3","article-title":"Ketamine cystitis following ketamine therapy for treatment-resistant depression - case report","volume":"24","author":"Chang","year":"2024","journal-title":"BMC Psychiatry"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0306-4603(85)90042-5","article-title":"Aversive conditioning of junk food consumption: A multiple baseline study","volume":"10","author":"Clapham","year":"1985","journal-title":"Addictive Behaviors"},{"key":"10.1016\/j.cpr.2026.102706_bb0135","series-title":"Ketamine-assisted psychotherapy for generalized anxiety disorder: A comprehensive case report with integrated neurophysiological imaging using magnetoencephalography. In","author":"Cohen","year":"2025"},{"key":"10.1016\/j.cpr.2026.102706_bb0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-3-642-25758-2_10","article-title":"Glutamatergic synaptic dysregulation in schizophrenia: Therapeutic implications","volume":"213","author":"Coyle","year":"2012","journal-title":"Handbook of Experimental Pharmacology"},{"key":"10.1016\/j.cpr.2026.102706_bb0145","author":"CPBAO"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1360-0443.2000.9545759.x","article-title":"Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later","volume":"95","author":"Curran","year":"2000","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40337-025-01313-y","article-title":"Reconnecting through dissociation: A 5-month follow-up case study on ketamine-assisted psychotherapy for anorexia nervosa","volume":"13","author":"Dahlgren","year":"2025","journal-title":"Journal of Eating Disorders"},{"key":"10.1016\/j.cpr.2026.102706_bb0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2013.12.019","article-title":"Therapeutic infusions of ketamine: Do the psychoactive effects matter?","volume":"136","author":"Dakwar","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0165","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/mp.2016.39","article-title":"Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: A randomized, crossover trial","volume":"22","author":"Dakwar","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0170","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1176\/appi.ajp.2019.19070684","article-title":"A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized midazolam-controlled pilot trial [article]","volume":"177","author":"Dakwar","year":"2020","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1016\/j.cpr.2026.102706_bb0175","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1176\/appi.ajp.2019.18101123","article-title":"A single ketamine infusion combined with mindfulness-based behavioral modification to treat cocaine dependence: A randomized clinical trial","volume":"176","author":"Dakwar","year":"2019","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0180","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.803279","article-title":"A cohort-based case report: The impact of ketamine-assisted therapy embedded in a community of practice framework for healthcare providers with PTSD and depression","volume":"12","author":"Dames","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"9","key":"10.1016\/j.cpr.2026.102706_bb0185","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1037\/h0037092","article-title":"Studies of aversive conditioning for alcoholics: A critical review of theory and research methodology","volume":"81","author":"Davidson","year":"1974","journal-title":"Psychological Bulletin"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1556\/2054.2021.00179","article-title":"Ketamine-assisted psychotherapy for trauma-exposed patients in an outpatient setting: A clinical chart review study","volume":"5","author":"Davis","year":"2021","journal-title":"Journal of Psychedelic Studies"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0195","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1080\/02791072.2018.1506599","article-title":"The Domino effect: Ed Domino\u2019s early studies of psychoactive drugs","volume":"50","author":"Denomme","year":"2018","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0200","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/ALN.0b013e3181ed09a2","article-title":"Taming the ketamine tiger. 1965","volume":"113","author":"Domino","year":"2010","journal-title":"Anesthesiology"},{"key":"10.1016\/j.cpr.2026.102706_bb0205","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/cpt196563279","article-title":"Pharmacologic effects of Ci-581, a new dissociative anesthetic, in man","volume":"6","author":"Domino","year":"1965","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/02791072.2019.1587556","article-title":"Ketamine assisted psychotherapy (KAP): Patient demographics, clinical data and outcomes in three large practices administering ketamine with psychotherapy","volume":"51","author":"Dore","year":"2019","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.cpr.2026.102706_bb0215","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/JPR.S360733","article-title":"Ketamine assisted psychotherapy: A systematic narrative review of the literature","volume":"15","author":"Drozdz","year":"2022","journal-title":"Journal of Pain Research"},{"issue":"11","key":"10.1016\/j.cpr.2026.102706_bb0220","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1038\/s41386-023-01606-3","article-title":"Long term structural and functional neural changes following a single infusion of ketamine in PTSD","volume":"48","author":"Duek","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0225","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nm.4050","article-title":"Synaptic plasticity and depression: New insights from stress and rapid-acting antidepressants","volume":"22","author":"Duman","year":"2016","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cpr.2026.102706_bb0230","doi-asserted-by":"crossref","first-page":"141","DOI":"10.24972\/ijts.2014.33.2.141","article-title":"Making ketamine work in the long run","volume":"33","author":"Early","year":"2014","journal-title":"International Journal of Transpersonal Studies"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0235","article-title":"Combining ketamine infusions and written exposure therapy for chronic PTSD: An open-label trial","volume":"86","author":"Feder","year":"2025","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0240","doi-asserted-by":"crossref","DOI":"10.1177\/2158244018824492","article-title":"Beyond four forces: The evolution of psychotherapy","volume":"9","author":"Fleuridas","year":"2019","journal-title":"SAGE Open"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0245","first-page":"434","article-title":"A case of ketamine dependence","volume":"21","author":"Florkowski","year":"1987","journal-title":"Psychiatria Polska"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0250","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1037\/pst0000172","article-title":"The alliance in adult psychotherapy: A meta-analytic synthesis","volume":"55","author":"Fl\u00fcckiger","year":"2018","journal-title":"Psychotherapy (Chicago, Ill.)"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0255","first-page":"32","article-title":"Antidepressive therapy with C1 581","volume":"20","author":"Fontana","year":"1974","journal-title":"Acta Psiqui\u00e1trica y Psicol\u00f3gica de Am\u00e9rica Latina"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0260","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1176\/appi.ajp.20240515","article-title":"Esketamine treatment for depression in adults: A PRISMA systematic review and Meta-analysis","volume":"182","author":"Fountoulakis","year":"2025","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0265","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/02791072.2023.2248989","article-title":"Therapeutic protocols using ketamine and Esketamine for depressive disorders: A systematic review","volume":"56","author":"Freind","year":"2023","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0270","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13191","article-title":"Esketamine nasal spray for rapid reduction of major depressive disorder symptoms in patients who have active suicidal ideation with intent: Double-blind, randomized study (ASPIRE I)","volume":"81","author":"Fu","year":"2020","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0275","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/09540261.2018.1486289","article-title":"Current perspectives on psychedelic therapy: Use of serotonergic hallucinogens in clinical interventions","volume":"30","author":"Garcia-Romeu","year":"2018","journal-title":"International Review of Psychiatry"},{"issue":"6","key":"10.1016\/j.cpr.2026.102706_bb0280","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/02698811241254834","article-title":"Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems","volume":"38","author":"Gent","year":"2024","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0285","first-page":"297","article-title":"Ketamine abreaction\u202f: A new approach to narcoanalysis","volume":"28","author":"Golechha","year":"1986","journal-title":"Indian Journal of Psychiatry"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0290","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2021.21030277","article-title":"Adjunctive ketamine with relapse prevention\u2013based psychological therapy in the treatment of alcohol use disorder","volume":"179","author":"Grabski","year":"2022","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0295","series-title":"LSD psychotherapy","author":"Grof","year":"1980"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0300","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1177\/1363461520983684","article-title":"Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy","volume":"59","author":"Gukasyan","year":"2022","journal-title":"Transcult Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/02698811241267837","article-title":"Compassionate use of esketamine intranasal in patients with severe major depressive disorder resistant to the treatment [article]","volume":"39","author":"Guti\u00e9rrez-Rojas","year":"2025","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0310","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/1534650121990894","article-title":"Ketamine-assisted psychotherapy for PTSD related to racial discrimination","volume":"20","author":"Halstead","year":"2021","journal-title":"Clinical Case Studies"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0315","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"The British Journal of Medical Psychology"},{"key":"10.1016\/j.cpr.2026.102706_bb0320","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1322679","article-title":"Case report: Adult with bipolar disorder and autism treated with ketamine assisted psychotherapy [article]","volume":"15","author":"Harris","year":"2024","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0325","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1092852919001007","article-title":"Toward specific ways to combine ketamine and psychotherapy in treating depression","volume":"25","author":"Hasler","year":"2020","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.cpr.2026.102706_bb0330","doi-asserted-by":"crossref","DOI":"10.1080\/02791072.2025.2449911","article-title":"Ketamine-assisted psychotherapy for antisocial personality disorder: A case report","author":"Hicks","year":"2025","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0335","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2215-0366(17)30513-8","article-title":"The lancet psychiatry commission on psychological treatments research in tomorrow\u2019s science","volume":"5","author":"Holmes","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0340","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1037\/a0022186","article-title":"Alliance in individual psychotherapy","volume":"48","author":"Horvath","year":"2011","journal-title":"Psychotherapy (Chicago, Ill.)"},{"key":"10.1016\/j.cpr.2026.102706_bb0345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jad.2022.07.004","article-title":"At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label effectiveness trial","volume":"314","author":"Hull","year":"2022","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0350","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1176\/ajp.151.5.779a","article-title":"A case of ketamine dependence","volume":"151","author":"Hurt","year":"1994","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0355","article-title":"JBI critical appraisal-checklist for systematic reviews and research syntheses","author":"Institute, J. B","year":"2020","journal-title":"JBI"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0360","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/ijnp\/pyaa068","article-title":"Esketamine nasal spray for rapid reduction of depressive symptoms in patients with major depressive disorder who have active suicide ideation with intent: Results of a phase 3, double-blind, randomized study (ASPIRE II)","volume":"24","author":"Ionescu","year":"2021","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.cpr.2026.102706_bb0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113804","article-title":"The safety and efficacy of ketamine NMDA receptor blocker as a therapeutic intervention for PTSD review of a randomized clinical trial","volume":"424","author":"Jumaili","year":"2022","journal-title":"Behavioural Brain Research"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0370","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1159\/000507095","article-title":"Continuous ketamine infusion for pain as an opportunity for psychotherapy for PTSD: A case series of ketamine-enhanced psychotherapy for PTSD and pain (KEP-P2)","volume":"89","author":"Keizer","year":"2020","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0375","doi-asserted-by":"crossref","DOI":"10.1192\/bjo.2023.53","article-title":"Ketamine and psychotherapy for the treatment of psychiatric disorders: Systematic review","volume":"9","author":"Kew","year":"2023","journal-title":"BJPsych Open"},{"issue":"6","key":"10.1016\/j.cpr.2026.102706_bb0380","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0033-3182(73)71306-2","article-title":"The use of ketamine in psychiatry","volume":"14","author":"Khorramzadeh","year":"1973","journal-title":"Psychosomatics"},{"key":"10.1016\/j.cpr.2026.102706_bb0385","doi-asserted-by":"crossref","first-page":"84","DOI":"10.24972\/ijts.2014.33.2.84","article-title":"Ketamine psychedelic psychotherapy: Focus on its pharmacology, phenomenology, and clinical applications","volume":"33","author":"Kolp","year":"2014","journal-title":"International Journal of Transpersonal Studies"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0390","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1207\/s15473333thp3404_7","article-title":"Ketamine enhanced psychotherapy: Preliminary clinical observations on its effectiveness in treating alcoholism","volume":"34","author":"Kolp","year":"2006","journal-title":"The Humanistic Psychologist"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.24972\/ijts.2007.26.1.1","article-title":"Ketamine-enhanced psychotherapy: Preliminary clinical observations on its effects in treating death anxiety","volume":"26","author":"Kolp","year":"2007","journal-title":"International Journal of Transpersonal Studies"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0400","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/02791072.2007.10399860","article-title":"Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence","volume":"39","author":"Krupitsky","year":"2007","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.cpr.2026.102706_bb0405","first-page":"88","article-title":"Ketamine-assisted psychotherapy (KPT) of heroin addiction: Immediate effects and six months follow-up","volume":"2","author":"Krupitsky","year":"2001","journal-title":"The Heffter Review of Psychedelic Research"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0410","first-page":"32","article-title":"Ketamine psychotherapy: Results and mechanisms","volume":"15","author":"Krupitsky","year":"1996","journal-title":"International Journal of Transpersonal Studies"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0415","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1300\/J020V09N01_09","article-title":"The combination of psychedelic and aversive approaches in alcoholism treatment: The affective contra-attribution method","volume":"9","author":"Krupitsky","year":"1992","journal-title":"Alcoholism Treatment Quarterly"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0420","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4097\/kja.20663","article-title":"Comeback of ketamine: Resurfacing facts and dispelling myths","volume":"74","author":"Kumar","year":"2021","journal-title":"Korean Journal of Anesthesiology"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0425","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/npp.1993.69","article-title":"Before they called it psychopharmacology","volume":"8","author":"Lehmann","year":"1993","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0430","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/s41598-019-43746-x","article-title":"A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan","volume":"9","author":"Li","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1016\/j.cpr.2026.102706_bb0435","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3389\/fnhum.2016.00612","article-title":"Ketamine: 50 years of modulating the mind","volume":"10","author":"Li","year":"2016","journal-title":"Frontiers in Human Neuroscience"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0440","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0005-7967(68)90012-0","article-title":"Aversive conditioning of drug addicts: A pilot study","volume":"6","author":"Liberman","year":"1968","journal-title":"Behaviour Research and Therapy"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0445","first-page":"31","article-title":"Ketamine associated psychedelic effects and dependence","volume":"44","author":"Lim","year":"2003","journal-title":"Singapore Medical Journal"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0450","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00228-021-03216-8","article-title":"Use of ketamine and esketamine for depression: An overview of systematic reviews with meta-analyses","volume":"78","author":"Lima","year":"2022","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0455","first-page":"329","article-title":"The history of barbiturates a century after their clinical introduction","volume":"1","author":"Lopez-Munoz","year":"2005","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0460","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/02698811241286726","article-title":"Rapid and sustained reduction of treatment-resistant PTSD symptoms after intravenous ketamine in a real-world, psychedelic paradigm [article]","volume":"39","author":"MacConnel","year":"2025","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.cpr.2026.102706_bb0465","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1080\/28376811.2024.2371792","article-title":"'Angry at the wrong thing:' queering ketamine assisted psychotherapy for clients experiencing body image and eating distress","volume":"94","author":"Maguire","year":"2024","journal-title":"Studies in Clinical Social Work: Transforming Practice, Education and Research"},{"issue":"7","key":"10.1016\/j.cpr.2026.102706_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11070856","article-title":"Therapeutic potentials of ketamine and Esketamine in obsessive-compulsive disorder (OCD), substance use disorders (SUD) and eating disorders (ED): A review of the current literature","volume":"11","author":"Martinotti","year":"2021","journal-title":"Brain Sciences"},{"key":"10.1016\/j.cpr.2026.102706_bb0475","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jad.2024.05.131","article-title":"At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data","volume":"361","author":"Mathai","year":"2024","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.cpr.2026.102706_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.868103","article-title":"Toward synergies of ketamine and psychotherapy","volume":"13","author":"Mathai","year":"2022","journal-title":"Frontiers in Psychology"},{"key":"10.1016\/j.cpr.2026.102706_bb0485","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1192\/bjp.129.6.556","article-title":"Is a homosexual orientation irreversible?","volume":"129","author":"McConaghy","year":"1976","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0490","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jad.2020.06.050","article-title":"The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis","volume":"276","author":"McIntyre","year":"2020","journal-title":"Journal of Affective Disorders"},{"issue":"9","key":"10.1016\/j.cpr.2026.102706_bb0495","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/EJA.0000000000000638","article-title":"History of anaesthesia: The ketamine story - past, present and future","volume":"34","author":"Mion","year":"2017","journal-title":"European Journal of Anaesthesiology"},{"issue":"6","key":"10.1016\/j.cpr.2026.102706_bb0500","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/s41591-021-01336-3","article-title":"MDMA-assisted therapy for severe PTSD: A randomized, double-blind, placebo-controlled phase 3 study","volume":"27","author":"Mitchell","year":"2021","journal-title":"Nature Medicine"},{"key":"10.1016\/j.cpr.2026.102706_bb0505","series-title":"A manual for MDMA-assisted psychotherapy in the treatment of posttraumatic stress disorder in MAPS (Ed.)","author":"Mithoefer","year":"2017"},{"issue":"7","key":"10.1016\/j.cpr.2026.102706_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.cpr.2026.102706_bb0515","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0520","series-title":"Ketamine-assisted psychotherapy: Clinical outcomes and self-transcendence in depression and post-traumatic stress disorder","author":"Montjoy","year":"2022"},{"key":"10.1016\/j.cpr.2026.102706_bb0525","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jad.2025.04.041","article-title":"Combined ketamine and psychotherapy provide no additional benefit beyond ketamine alone in treating depression or PTSD: Evidence from a help-seeking sample","volume":"381","author":"Moore","year":"2025","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0530","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1360-0443.2011.03576.x","article-title":"Ketamine use: A review","volume":"107","author":"Morgan","year":"2012","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0535","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1360-0443.2008.02394.x","article-title":"Ketamine use, cognition and psychological wellbeing: A comparison of frequent, infrequent and ex-users with polydrug and non-using controls","volume":"104","author":"Morgan","year":"2009","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0540","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1360-0443.2009.02761.x","article-title":"Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: A 1-year longitudinal study","volume":"105","author":"Morgan","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0545","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0893-133X(98)00067-0","article-title":"Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis","volume":"20","author":"Newcomer","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cpr.2026.102706_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102127","article-title":"Ketamine for the treatment of major depression: A systematic review and meta-analysis","volume":"62","author":"Nikolin","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0555","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/papr.12829","article-title":"Ketamine and cognitive behavioral therapy for rapid opioid tapering with sustained opioid abstinence: A case report and 1-year follow-up","volume":"20","author":"Ocker","year":"2020","journal-title":"Pain Practice"},{"key":"10.1016\/j.cpr.2026.102706_bb0560","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2024.1427531","article-title":"The conceptual framework for the therapeutic approach used in phase 3 trials of MDMA-assisted therapy for PTSD","volume":"15","author":"O\u2019Donnell","year":"2024","journal-title":"Frontiers in Psychology"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0565","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.brat.2007.12.005","article-title":"Efficacy of the third wave of behavioral therapies: A systematic review and meta-analysis","volume":"46","author":"Ost","year":"2008","journal-title":"Behaviour Research and Therapy"},{"key":"10.1016\/j.cpr.2026.102706_bb0570","unstructured":"Oswin, S. L. (2023). Differences in PHQ-9 depression severity between adults receiving ketamine or ketamine-assisted psychotherapy ProQuest Information & Learning]. Psyh. http:\/\/search.ebscohost.com.proxy-ub.rug.nl\/login.aspx?direct=true&db=psyh&AN=2023-55665-133&site=ehost-live&scope=site."},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0575","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1177\/0310057X0203000323","article-title":"Ketamine dependence","volume":"30","author":"Pal","year":"2002","journal-title":"Anaesthesia and Intensive Care"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.psycr.2025.100259","article-title":"Qualitative analysis of a patient\u2019s experience of ketamine-assisted psychotherapy for substance use disorder: Empirical synergies with twelve-step programs","volume":"4","author":"Petrovitch","year":"2025","journal-title":"Psychiatry Research Case Reports"},{"key":"10.1016\/j.cpr.2026.102706_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.jadr.2023.100613","article-title":"Sustaining the benefits of intravenous ketamine with behavioural activation therapy for depression: A case series [article]","volume":"14","author":"Phillips","year":"2023","journal-title":"Journal of Affective Disorders Reports"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0590","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1176\/appi.ajp.2018.18070834","article-title":"Single, repeated, and maintenance ketamine infusions for treatment-resistant depression: A randomized controlled trial","volume":"176","author":"Phillips","year":"2019","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0595","series-title":"Yoga and mindfulness based cognitive therapy: A clinical guide","author":"Pradhan","year":"2014"},{"issue":"7","key":"10.1016\/j.cpr.2026.102706_bb0600","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbapap.2018.03.006","article-title":"d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: A pilot study","volume":"1866","author":"Pradhan","year":"2018","journal-title":"Biochimica et Biophysica Acta, Proteins and Proteomics"},{"issue":"11","key":"10.1016\/j.cpr.2026.102706_bb0605","article-title":"Combining ketamine, brain stimulation (rTMS) and mindfulness therapy (TIMBER) for opioid addiction","volume":"12","author":"Pradhan","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.cpr.2026.102706_bb0610","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/2542-3932.211589","volume":"2","author":"Pradhan","year":"2017","journal-title":"Asia Pacific Journal of Clinical Trials Nervous System Diseases"},{"key":"10.1016\/j.cpr.2026.102706_bb0615","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.764112","article-title":"Case report: Unexpected remission from extreme and enduring bulimia nervosa with repeated ketamine assisted psychotherapy","volume":"12","author":"Ragnhildstveit","year":"2021","journal-title":"Frontiers in Psychiatry"},{"issue":"9477","key":"10.1016\/j.cpr.2026.102706_bb0620","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1016\/S0140-6736(05)66737-2","article-title":"Recognition and management of complications of new recreational drug use","volume":"365","author":"Ricaurte","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0625","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11606-014-2980-0","article-title":"The role of professional societies in limiting indication creep","volume":"30","author":"Riggs","year":"2015","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.cpr.2026.102706_bb0630","article-title":"Ketamine-assisted group psychotherapy for frontline healthcare workers with COVID-19-related burnout and PTSD: A case series of effectiveness\/safety for 10 participants [article in press]","author":"Robison","year":"2023","journal-title":"Journal of Psychoactive Drugs"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0635","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40337-022-00588-9","article-title":"A case series of group-based ketamine-assisted psychotherapy for patients in residential treatment for eating disorders with comorbid depression and anxiety disorders","volume":"10","author":"Robison","year":"2022","journal-title":"Journal of Eating Disorders"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0640","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/02791072.2017.1371364","article-title":"Delayed urinary symptoms induced by ketamine","volume":"50","author":"Robles-Martinez","year":"2018","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.cpr.2026.102706_bb0645","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1325399","article-title":"Efficacy and safety of ketamine and esketamine for unipolar and bipolar depression: An overview of systematic reviews with meta-analysis","volume":"15","author":"Rodolico","year":"2024","journal-title":"Frontiers in Psychiatry"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0650","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4088\/JCP.15l10138","article-title":"Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? An open-label trial","volume":"77","author":"Rodriguez","year":"2016","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"8","key":"10.1016\/j.cpr.2026.102706_bb0655","article-title":"Combined effects of nasal ketamine and trauma-focused psychotherapy in treatment-resistant post-traumatic stress disorder: A pilot case series","volume":"14","author":"Rohde","year":"2024","journal-title":"Behavioural Sciences (Basel)"},{"key":"10.1016\/j.cpr.2026.102706_bb0660","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1939-0025.1936.tb05248.x","article-title":"Some implicit common factors in diverse methods of psychotherapy","volume":"6","author":"Rosenzweig","year":"1936","journal-title":"American Journal of Orthopsychiatry"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0665","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/0269881120970879","article-title":"Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial","volume":"35","author":"Rothberg","year":"2020","journal-title":"Journal of Psychopharmacology"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejtd.2024.100490","article-title":"Esketamine facilitate psychotherapies for post-traumatic stress disorder: A retrospective case series of six patients","volume":"9","author":"Roullet","year":"2025","journal-title":"European Journal of Trauma & Dissociation"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0675","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0165-1781(86)90060-0","article-title":"The inventory for depressive symptomatology (IDS): Preliminary findings","volume":"18","author":"Rush","year":"1986","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.cpr.2026.102706_bb0680","article-title":"Maintenance intramuscular ketamine-assisted psychotherapy, a retrospective chart review of efficacy, adverse events, and dropouts from a community practice","volume":"1-15","author":"Ryan","year":"2024","journal-title":"Journal of Psychoactive Drugs"},{"issue":"14","key":"10.1016\/j.cpr.2026.102706_bb0685","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146673","article-title":"The effects of psychotherapy on single and repeated ketamine infusion(s) therapy for treatment-resistant depression: The convergence of molecular and psychological treatment","volume":"26","author":"Sakopoulos","year":"2025","journal-title":"International Journal of Molecular Sciences"},{"issue":"10","key":"10.1016\/j.cpr.2026.102706_bb0690","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1176\/appi.ajp.20240655","article-title":"Real-world safety of Esketamine nasal spray: A comprehensive analysis almost 5 years after first approval","volume":"182","author":"Sanacora","year":"2025","journal-title":"The American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0695","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00213-021-06027-y","article-title":"Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: A systematic review","volume":"239","author":"Schimmers","year":"2022","journal-title":"Psychopharmacology"},{"issue":"9","key":"10.1016\/j.cpr.2026.102706_bb0700","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/s41591-023-02378-5","article-title":"Psychedelic treatments for mental health conditions pose challenges for informed consent","volume":"29","author":"Seybert","year":"2023","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0705","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S2215-0366(24)00333-X","article-title":"Quality of reporting on psychological interventions in psychedelic treatments: A systematic review","volume":"12","author":"Seybert","year":"2025","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0710","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41398-020-00897-0","article-title":"A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression","volume":"10","author":"Shiroma","year":"2020","journal-title":"Translational Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0715","doi-asserted-by":"crossref","DOI":"10.1089\/jpm.2024.0346","article-title":"Ketamine and ketamine-assisted psychotherapy for psychiatric and existential distress in patients with serious medical illness: A narrative review","author":"Sholevar","year":"2025","journal-title":"Journal of Palliative Medicine"},{"issue":"11","key":"10.1016\/j.cpr.2026.102706_bb0720","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S2215-0366(22)00317-0","article-title":"Maintenance ketamine treatment for depression: A systematic review of efficacy, safety, and tolerability","volume":"9","author":"Smith-Apeldoorn","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"18","key":"10.1016\/j.cpr.2026.102706_bb0725","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/jama.282.18.1737","article-title":"Validation and utility of a self-report version of PRIME-MD: The PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire","volume":"282","author":"Spitzer","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.cpr.2026.102706_bb0730","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: The GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.cpr.2026.102706_bb0735","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cpr.2026.102706_bb0740","series-title":"Integrative psychotherapies","author":"Stricker","year":"2008"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0745","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s40263-022-00897-2","article-title":"Non-parenteral ketamine for depression: A practical discussion on addiction potential and recommendations for judicious prescribing","volume":"36","author":"Swainson","year":"2022","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.cpr.2026.102706_bb0750","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40337-024-01039-3","article-title":"Improvement in depressive symptoms in a patient with severe and enduring anorexia nervosa and comorbid major depressive disorder using psychotherapy-assisted IV ketamine : A case report","volume":"12","author":"Timek","year":"2024","journal-title":"Journal of Eating Disorders"},{"key":"10.1016\/j.cpr.2026.102706_bb0755","doi-asserted-by":"crossref","DOI":"10.1097\/JOM.0000000000003352","article-title":"The effect of ketamine-assisted group therapy on treatment-resistant mental health conditions in firefighters: A prospective observational case series","author":"Tsang","year":"2025","journal-title":"Journal of Occupational and Environmental Medicine"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0760","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1080\/02791072.2023.2253798","article-title":"A pilot study comparing a Community of Practice Program with and without concurrent ketamine-assisted therapy","volume":"56","author":"Tsang","year":"2024","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.cpr.2026.102706_bb0765","article-title":"A pilot study comparing a Community of Practice Program with and without concurrent ketamine-assisted therapy [article in press]","author":"Tsang","year":"2023","journal-title":"Journal of Psychoactive Drugs"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0770","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/wps.20238","article-title":"How important are the common factors in psychotherapy? An update","volume":"14","author":"Wampold","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0775","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1160442","article-title":"Reductions in anxiety and depression symptoms in a subset of outpatients with problematic substance use who received ketamine-assisted psychotherapy: A two-year retrospective chart review [article]","volume":"14","author":"Whinkin","year":"2023","journal-title":"Frontiers in Psychiatry"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0780","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1176\/appi.ajp.2017.17040472","article-title":"The effect of a single dose of intravenous ketamine on suicidal ideation: A systematic review and individual participant data Meta-analysis","volume":"175","author":"Wilkinson","year":"2018","journal-title":"The American Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0785","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000517074","article-title":"Cognitive behavioral therapy to sustain the antidepressant effects of ketamine in treatment-resistant depression: A randomized clinical trial","volume":"90","author":"Wilkinson","year":"2021","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0790","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000457960","article-title":"Cognitive behavior therapy may sustain antidepressant effects of intravenous ketamine in treatment-resistant depression","volume":"86","author":"Wilkinson","year":"2017","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.cpr.2026.102706_bb0795","unstructured":"Willen, S. S. M. (2024). A program evaluation of ketamine assisted psychotherapy for treatment-resistant depression ProQuest Information & Learning]. Psyh. http:\/\/search.ebscohost.com.proxy-ub.rug.nl\/login.aspx?direct=true&db=psyh&AN=2024-65491-288&site=ehost-live&scope=site."},{"key":"10.1016\/j.cpr.2026.102706_bb0800","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1020214","article-title":"Case report: Medical student types journals during ketamine infusions for suicidal ideation, treatment-resistant depression, post-traumatic stress disorder, and generalized anxiety disorder [article]","volume":"13","author":"Willms","year":"2022","journal-title":"Frontiers in Psychiatry"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0805","doi-asserted-by":"crossref","first-page":"160","DOI":"10.24972\/ijts.2014.33.2.160","article-title":"Psychedelic experiential pharmacology: Pioneering clinical explorations with Salvador Roquet (how I came to all of this: Ketamine, admixtures and adjuvants, Don Juan and Carlos Castaneda too): An interview with Richard Yensen","volume":"33","author":"Wolfson","year":"2014","journal-title":"International Journal of Transpersonal Studies"},{"key":"10.1016\/j.cpr.2026.102706_bb0810","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1141988","article-title":"Ketamine-assisted psychotherapy in adolescents with multiple psychiatric diagnoses [article]","volume":"14","author":"Wolfson","year":"2023","journal-title":"Frontiers in Psychiatry"},{"key":"10.1016\/j.cpr.2026.102706_bb0815","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jpsychires.2020.12.038","article-title":"The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis","volume":"134","author":"Xiong","year":"2021","journal-title":"Journal of Psychiatric Research"},{"issue":"2","key":"10.1016\/j.cpr.2026.102706_bb0820","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1521\/pedi.2025.39.2.170","article-title":"Ketamine-assisted psychotherapy for treatment of co-occurring borderline personality disorder and depression: A case study [article]","volume":"39","author":"Yeung","year":"2025","journal-title":"Journal of Personality Disorders"},{"issue":"3","key":"10.1016\/j.cpr.2026.102706_bb0825","article-title":"Pharmacotherapy and ketamine assisted psychotherapy for treatment-resistant depression: A patient with lifelong self-doubt and self-criticism [article]","volume":"84","author":"Yeung","year":"2023","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1016\/j.cpr.2026.102706_bb0830","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/JCP.0000000000001726","article-title":"Challenges with short-term use of intravenous racemic ketamine with psychotherapy for a hospitalized patient with severe posttraumatic stress disorder and depression","volume":"43","author":"Zambrano","year":"2023","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.cpr.2026.102706_bb0835","doi-asserted-by":"crossref","first-page":"106","DOI":"10.24018\/ejmed.2021.3.4.979","article-title":"Efficacy of Oral ketamine combined with psychotherapy for treatment resistant depression","volume":"3","author":"Zdyb","year":"2021","journal-title":"European Journal of Medical and Health Sciences"}],"container-title":["Clinical Psychology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735826000152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272735826000152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T22:48:07Z","timestamp":1772491687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272735826000152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":167,"alternative-id":["S0272735826000152"],"URL":"https:\/\/doi.org\/10.1016\/j.cpr.2026.102706","relation":{},"ISSN":["0272-7358"],"issn-type":[{"value":"0272-7358","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Psychology Review","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpr.2026.102706","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102706"}}